US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 26.820
  • -0.180-0.67%
Trading Apr 30 14:08 ET
1.24BMarket Cap-12.47P/E (TTM)

Pacira BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
3.85%700.97M
3.32%187.25M
2.83%168.57M
5.05%178.02M
4.23%167.12M
1.22%674.98M
5.40%181.24M
-2.11%163.93M
0.03%169.47M
1.49%160.34M
Operating revenue
3.85%700.97M
3.32%187.25M
2.83%168.57M
5.05%178.02M
4.23%167.12M
1.22%674.98M
5.40%181.24M
-2.11%163.93M
0.03%169.47M
1.49%160.34M
Cost of revenue
-7.71%170.43M
-16.37%39.89M
-2.23%38.86M
-8.18%44.26M
-3.27%47.42M
-7.34%184.67M
-22.97%47.69M
-21.56%39.75M
-4.78%48.21M
35.89%49.02M
Gross profit
8.20%530.54M
10.34%147.37M
4.46%129.71M
10.31%133.76M
7.53%119.7M
4.87%490.31M
21.37%133.55M
6.33%124.18M
2.08%121.26M
-8.69%111.32M
Operating expense
7.44%432.96M
18.32%117.83M
4.52%107.76M
4.89%102.79M
2.23%104.59M
1.61%402.99M
3.96%99.59M
8.51%103.1M
-7.21%98M
2.11%102.31M
Selling and administrative expenses
9.15%294.1M
20.99%79.61M
9.40%74.33M
5.05%68.13M
1.67%72.03M
5.86%269.44M
2.86%65.8M
10.87%67.95M
-0.24%64.85M
10.24%70.84M
-Selling and marketing expense
12.40%172.02M
40.86%50.34M
12.89%43.19M
4.23%39.05M
-5.16%39.44M
--153.04M
--35.74M
13.51%38.26M
1.65%37.46M
8.17%41.58M
-General and administrative expense
4.88%122.08M
-2.63%29.27M
4.90%31.14M
6.17%29.08M
11.37%32.59M
--116.4M
--30.06M
7.65%29.69M
-2.70%27.39M
13.34%29.26M
Research and development costs
6.98%81.58M
22.78%23.9M
-8.29%19.1M
8.04%20.34M
6.41%18.24M
-10.07%76.26M
11.19%19.46M
7.34%20.83M
-28.38%18.82M
-20.67%17.14M
Depreciation amortization depletion
0.00%57.29M
0.00%14.32M
0.00%14.32M
0.00%14.32M
0.00%14.32M
0.00%57.29M
0.00%14.32M
0.00%14.32M
0.00%14.32M
0.00%14.32M
-Depreciation and amortization
0.00%57.29M
0.00%14.32M
0.00%14.32M
0.00%14.32M
0.00%14.32M
0.00%57.29M
0.00%14.32M
0.00%14.32M
0.00%14.32M
0.00%14.32M
Operating profit
11.74%97.57M
-13.05%29.53M
4.14%21.95M
33.15%30.98M
67.65%15.12M
23.12%87.32M
138.49%33.97M
-3.22%21.08M
76.55%23.26M
-58.51%9.02M
Net non-operating interest income expense
135.21%3.12M
2,264.86%875K
213.61%793K
149.32%865K
109.11%587K
74.99%-8.86M
100.45%37K
91.90%-698K
79.56%-1.75M
35.37%-6.45M
Non-operating interest income
72.05%19.69M
62.19%5.56M
98.19%5.48M
124.96%4.75M
24.22%3.9M
151.96%11.44M
22.98%3.43M
124.15%2.77M
737.70%2.11M
1,059.41%3.14M
Non-operating interest expense
-22.36%13.44M
41.84%3.83M
38.40%3.85M
-1.67%3.12M
-69.54%2.64M
-51.34%17.31M
-71.83%2.7M
-68.94%2.78M
-60.12%3.17M
-4.58%8.65M
Total other finance cost
4.47%3.13M
23.50%846K
22.99%840K
10.42%763K
-27.32%681K
-31.91%3M
-52.56%685K
-24.36%683K
-20.94%691K
-20.53%937K
Other net income (expense)
-877.33%-163.8M
-1,625.44%-4.88M
-4,177.37%-161.6M
-70.97%4.74M
92.90%-2.06M
24.47%-16.76M
98.82%-283K
65.92%-3.78M
-6.13%16.34M
-551.04%-29.04M
Special income (charges)
-886.04%-163.43M
-505.26%-4.83M
-4,711.59%-161.48M
-71.21%4.78M
93.45%-1.9M
-52.01%-16.57M
96.69%-798K
-586.30%-3.36M
-8.00%16.61M
-569.43%-29.03M
-Less：Restructuring and merger&acquisition
2,288.07%7.7M
505.26%4.83M
-152.62%-1.77M
116.46%2.74M
-84.28%1.9M
-103.23%-352K
-96.69%798K
586.30%3.36M
8.00%-16.61M
179.16%12.11M
-Less:Impairment of capital assets
--163.24M
--0
--163.24M
----
----
--0
--0
--0
----
----
-Less:Other special charges
-144.42%-7.52M
--0
----
---7.52M
----
--16.93M
--0
----
----
--16.93M
Other non- operating income (expenses)
-100.54%-373K
-110.29%-53K
71.09%-122K
85.50%-39K
-1,490.00%-159K
98.35%-186K
535.80%515K
96.02%-422K
58.42%-269K
91.94%-10K
Income before tax
-202.28%-63.11M
-24.30%25.53M
-936.43%-138.86M
-3.35%36.58M
151.52%13.64M
363.85%61.7M
286.63%33.72M
702.37%16.6M
72.01%37.85M
-462.96%-26.47M
Income tax
84.61%36.45M
7.18%9.49M
-19.73%4.61M
46.37%17.7M
167.18%4.66M
857.42%19.75M
211.10%8.85M
107.93%5.74M
467.39%12.09M
-1,588.84%-6.94M
Net income
-337.30%-99.56M
-35.50%16.04M
-1,421.29%-143.47M
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
Net income continuous Operations
-337.30%-99.56M
-35.50%16.04M
-1,421.29%-143.47M
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
Minority interest income
Net income attributable to the parent company
-337.30%-99.56M
-35.50%16.04M
-1,421.29%-143.47M
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-337.30%-99.56M
-35.50%16.04M
-1,421.29%-143.47M
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
Basic earnings per share
-336.26%-2.15
-35.19%0.35
-1,452.17%-3.11
-26.79%0.41
144.19%0.19
160.00%0.91
345.45%0.54
1,250.00%0.23
27.27%0.56
-386.67%-0.43
Diluted earnings per share
-341.57%-2.15
-34.62%0.34
-1,452.17%-3.11
-23.53%0.39
144.19%0.19
161.76%0.89
336.36%0.52
1,250.00%0.23
27.50%0.51
-386.67%-0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 3.85%700.97M3.32%187.25M2.83%168.57M5.05%178.02M4.23%167.12M1.22%674.98M5.40%181.24M-2.11%163.93M0.03%169.47M1.49%160.34M
Operating revenue 3.85%700.97M3.32%187.25M2.83%168.57M5.05%178.02M4.23%167.12M1.22%674.98M5.40%181.24M-2.11%163.93M0.03%169.47M1.49%160.34M
Cost of revenue -7.71%170.43M-16.37%39.89M-2.23%38.86M-8.18%44.26M-3.27%47.42M-7.34%184.67M-22.97%47.69M-21.56%39.75M-4.78%48.21M35.89%49.02M
Gross profit 8.20%530.54M10.34%147.37M4.46%129.71M10.31%133.76M7.53%119.7M4.87%490.31M21.37%133.55M6.33%124.18M2.08%121.26M-8.69%111.32M
Operating expense 7.44%432.96M18.32%117.83M4.52%107.76M4.89%102.79M2.23%104.59M1.61%402.99M3.96%99.59M8.51%103.1M-7.21%98M2.11%102.31M
Selling and administrative expenses 9.15%294.1M20.99%79.61M9.40%74.33M5.05%68.13M1.67%72.03M5.86%269.44M2.86%65.8M10.87%67.95M-0.24%64.85M10.24%70.84M
-Selling and marketing expense 12.40%172.02M40.86%50.34M12.89%43.19M4.23%39.05M-5.16%39.44M--153.04M--35.74M13.51%38.26M1.65%37.46M8.17%41.58M
-General and administrative expense 4.88%122.08M-2.63%29.27M4.90%31.14M6.17%29.08M11.37%32.59M--116.4M--30.06M7.65%29.69M-2.70%27.39M13.34%29.26M
Research and development costs 6.98%81.58M22.78%23.9M-8.29%19.1M8.04%20.34M6.41%18.24M-10.07%76.26M11.19%19.46M7.34%20.83M-28.38%18.82M-20.67%17.14M
Depreciation amortization depletion 0.00%57.29M0.00%14.32M0.00%14.32M0.00%14.32M0.00%14.32M0.00%57.29M0.00%14.32M0.00%14.32M0.00%14.32M0.00%14.32M
-Depreciation and amortization 0.00%57.29M0.00%14.32M0.00%14.32M0.00%14.32M0.00%14.32M0.00%57.29M0.00%14.32M0.00%14.32M0.00%14.32M0.00%14.32M
Operating profit 11.74%97.57M-13.05%29.53M4.14%21.95M33.15%30.98M67.65%15.12M23.12%87.32M138.49%33.97M-3.22%21.08M76.55%23.26M-58.51%9.02M
Net non-operating interest income expense 135.21%3.12M2,264.86%875K213.61%793K149.32%865K109.11%587K74.99%-8.86M100.45%37K91.90%-698K79.56%-1.75M35.37%-6.45M
Non-operating interest income 72.05%19.69M62.19%5.56M98.19%5.48M124.96%4.75M24.22%3.9M151.96%11.44M22.98%3.43M124.15%2.77M737.70%2.11M1,059.41%3.14M
Non-operating interest expense -22.36%13.44M41.84%3.83M38.40%3.85M-1.67%3.12M-69.54%2.64M-51.34%17.31M-71.83%2.7M-68.94%2.78M-60.12%3.17M-4.58%8.65M
Total other finance cost 4.47%3.13M23.50%846K22.99%840K10.42%763K-27.32%681K-31.91%3M-52.56%685K-24.36%683K-20.94%691K-20.53%937K
Other net income (expense) -877.33%-163.8M-1,625.44%-4.88M-4,177.37%-161.6M-70.97%4.74M92.90%-2.06M24.47%-16.76M98.82%-283K65.92%-3.78M-6.13%16.34M-551.04%-29.04M
Special income (charges) -886.04%-163.43M-505.26%-4.83M-4,711.59%-161.48M-71.21%4.78M93.45%-1.9M-52.01%-16.57M96.69%-798K-586.30%-3.36M-8.00%16.61M-569.43%-29.03M
-Less：Restructuring and merger&acquisition 2,288.07%7.7M505.26%4.83M-152.62%-1.77M116.46%2.74M-84.28%1.9M-103.23%-352K-96.69%798K586.30%3.36M8.00%-16.61M179.16%12.11M
-Less:Impairment of capital assets --163.24M--0--163.24M----------0--0--0--------
-Less:Other special charges -144.42%-7.52M--0-------7.52M------16.93M--0----------16.93M
Other non- operating income (expenses) -100.54%-373K-110.29%-53K71.09%-122K85.50%-39K-1,490.00%-159K98.35%-186K535.80%515K96.02%-422K58.42%-269K91.94%-10K
Income before tax -202.28%-63.11M-24.30%25.53M-936.43%-138.86M-3.35%36.58M151.52%13.64M363.85%61.7M286.63%33.72M702.37%16.6M72.01%37.85M-462.96%-26.47M
Income tax 84.61%36.45M7.18%9.49M-19.73%4.61M46.37%17.7M167.18%4.66M857.42%19.75M211.10%8.85M107.93%5.74M467.39%12.09M-1,588.84%-6.94M
Net income -337.30%-99.56M-35.50%16.04M-1,421.29%-143.47M-26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M
Net income continuous Operations -337.30%-99.56M-35.50%16.04M-1,421.29%-143.47M-26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M
Minority interest income
Net income attributable to the parent company -337.30%-99.56M-35.50%16.04M-1,421.29%-143.47M-26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -337.30%-99.56M-35.50%16.04M-1,421.29%-143.47M-26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M
Basic earnings per share -336.26%-2.15-35.19%0.35-1,452.17%-3.11-26.79%0.41144.19%0.19160.00%0.91345.45%0.541,250.00%0.2327.27%0.56-386.67%-0.43
Diluted earnings per share -341.57%-2.15-34.62%0.34-1,452.17%-3.11-23.53%0.39144.19%0.19161.76%0.89336.36%0.521,250.00%0.2327.50%0.51-386.67%-0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CG MED EQUIP.
838810
+29.98%
BEOKA
870199
+29.96%
Shenzhen Bromake New Material
301387
+20.01%
4
Zhejiang Hongchang Electrical Technology
301008
+20.00%
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.